Skip to main content

Table 3 Statistical performance of TBs of PI-RADS 4–5 versus PI-RADS 3–5 lesions in the MRI group

From: Impact of changing PI-RADS cutoff on prostate cancer detection by MRI cognitive fusion biopsy in biopsy-naïve patients

 

PI-RADS 3–5

PI-RADS 4–5

P value

% (95% CI)

% (95% CI)

Sensitivity

100.0%

(78.2–100)

73.3%

(44.9–92.2)

0.100#

Specificity

44.0%

(24.4–65.1)

100.0%

(86.0–100)

< 0.0001#

PPV

51.7%

(32.5–70.6)

100.0%

(71.5–100)

0.004#

NPV

100.0%

(71.5–100)

86.2%

(68.3–96.1)

0.560#

  1. Data were presented as percentages and 95% confidence interval
  2. #Fisher’s exact test